DV Biologics, System Biosciences Ink Stem Cell Partnership

Under the deal, System Biosciences will convert many of DV Biologics' disease-specific cell types into induced pluripotent stem cell lines.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.